SCHEMBL5360932

SCHEMBL5360932

O=C1c2cccc(N3CCNCC3)c2Oc2ccccc2N1CCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.55
ALDH1A1 P00352 4/20 0.46
ALDH2 P05091 2/20 0.46
ALDH3A1 P30838 2/20 0.46
PARK7 Q99497 1/20 0.46
GAA P10253 2/20 0.43
MAPT P10636 2/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ADRB1 P08588 1/20 0.43
HTR1A P08908 3/20 0.42
CASP3 P42574 1/20 0.41
APAF1 O14727 1/20 0.41
CASP1 P29466 1/20 0.41
BLM P54132 1/20 0.41
CASP7 P55210 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5429686 0.99 HTR6 (0.54) HTR6ALDH1A1ALDH2ALDH3A1PARK7
SCHEMBL5366706 0.94 HTR6 (0.54) HTR6ALDH1A1ALDH2ALDH3A1PARK7
Hydrochloric Acid SCHEMBL5357248 0.93 HTR6 (0.53) HTR6ALDH1A1ALDH2ALDH3A1PARK7
SCHEMBL5362209 0.89 HTR6 (0.61) HTR6ALDH1A1ALDH2ALDH3A1PARK7
SCHEMBL5364893 0.89 HTR6 (0.65) HTR6ALDH1A1ALDH2ALDH3A1MAPT
Hydrochloric Acid SCHEMBL5363890 0.89 HTR6 (0.60) HTR6ALDH1A1ALDH2ALDH3A1PARK7
SCHEMBL5360129 0.87 HTR6 (0.51) HTR6ALDH1A1ALDH2ALDH3A1PARK7
Hydrochloric Acid SCHEMBL5364749 0.86 HTR6 (0.50) HTR6ALDH1A1ALDH2ALDH3A1PARK7
SCHEMBL5357019 0.82 HTR6 (0.64) HTR6ALDH3A1GAAMAPTKDM4E
SCHEMBL5361817 0.82 HTR6 (0.64) HTR6MAPTSMN1; SMN2ADRB1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7229984-B2 Dibenzoxazepinone derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2007-06-12 US claimed
US-20060154914-A1 Dibenzoxazepinone derivatives and uses thereof ROCHE PALO ALTO LLC 2006-07-13 US claimed
US-7229984-B2 Dibenzoxazepinone derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2007-06-12 US disclosed
US-7229984-B2 Dibenzoxazepinone derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2007-06-12 US disclosed
US-20060154914-A1 Dibenzoxazepinone derivatives and uses thereof ROCHE PALO ALTO LLC 2006-07-13 US disclosed
WO-2006061126-A2 DIBENZOXAZEPINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154914-A1 Dibenzoxazepinone derivatives and uses thereof HTR6, BDKRB1, HTR7 HTR6 1/4885ALDH1A1 1336/4885ALDH2 2917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.